KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Twist Bioscience (TWST) Non-cash Items (2018 - 2021)

Twist Bioscience (TWST) has disclosed Non-cash Items for 4 consecutive years, with $1.6 million as the latest value for Q4 2021.

  • On a quarterly basis, Non-cash Items changed N/A to $1.6 million in Q4 2021 year-over-year; TTM through Dec 2021 was $1.6 million, a N/A change, with the full-year FY2021 number at $251.3 million, up 22.99% from a year prior.
  • Non-cash Items was $1.6 million for Q4 2021 at Twist Bioscience, down from $251.3 million in the prior quarter.
  • In the past five years, Non-cash Items ranged from a high of $342.0 million in Q1 2021 to a low of $1.6 million in Q2 2021.
  • A 4-year average of $110.8 million and a median of $37.2 million in 2018 define the central range for Non-cash Items.
  • Biggest YoY gain for Non-cash Items was 22.99% in 2021; the steepest drop was 22.99% in 2021.
  • Twist Bioscience's Non-cash Items stood at $37.2 million in 2018, then dropped by 0.43% to $37.1 million in 2019, then skyrocketed by 451.03% to $204.4 million in 2020, then crashed by 99.2% to $1.6 million in 2021.
  • Per Business Quant, the three most recent readings for TWST's Non-cash Items are $1.6 million (Q4 2021), $251.3 million (Q3 2021), and $1.6 million (Q2 2021).